| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/20/1999 | CN1205638A Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 01/20/1999 | CN1205637A Method for treating depression |
| 01/20/1999 | CN1205636A Injectable quinolone formulations |
| 01/20/1999 | CN1205635A Rotamase enzyme activity inhibitors |
| 01/20/1999 | CN1205634A Use of PDE inhibitors in manufacture of medicament for treatment of bladder diseases |
| 01/20/1999 | CN1205633A Thiamorphinans with neuroprotective activity |
| 01/20/1999 | CN1205632A Anti-helicobacter pylori agent |
| 01/20/1999 | CN1205631A Transdermal device for delivery of flurbiprofen |
| 01/20/1999 | CN1205630A Transdermal device for delivery of flurbiprofen |
| 01/20/1999 | CN1205629A Controlled release formulation for poorly soluble basic drugs |
| 01/20/1999 | CN1205339A Total esculentoside and treating application to endometriosis |
| 01/20/1999 | CN1205338A Synthetic method and medical application of azimycin water soluable salt |
| 01/20/1999 | CN1205335A Tricyclic diazepine vasopression antagonists |
| 01/20/1999 | CN1205328A Sulfonylaminocarboxylic acids |
| 01/20/1999 | CN1205327A Amidate having retardation to angiotensin II acceptor, its prepn. method and application |
| 01/20/1999 | CN1205229A Medicine for treating pointed condyloma |
| 01/20/1999 | CN1205225A External-use medicine for treating superficial skin fungus disease |
| 01/20/1999 | CN1205224A Clear-heading agent and its prepn. method |
| 01/20/1999 | CN1205206A Use of tetrahydrofolates in natural stereoisomeric form for production of pharmaceutical preparation suitable for influencing homocystenie level, particularly for assisting remethylation of homocystei |
| 01/20/1999 | CN1205205A Pyrazolopyridine compound and processes for preparation thereof |
| 01/20/1999 | CN1041731C Pyrido [1,2,3-d,3)(1,3,4) benzoxadiazine derivatives |
| 01/20/1999 | CN1041730C Method for preparing tetrahydrothienopyridine derivatives |
| 01/20/1999 | CN1041727C Risperidone pamoate salt, its prepn. method and medicinal compsns. containing same |
| 01/20/1999 | CN1041726C Method for preparing 1,3-dihydro-2h-imidzo [4,5,6] quinoline-2-one derivatives |
| 01/20/1999 | CN1041723C Organic salts of N,N'-diacetyl cystine |
| 01/20/1999 | CN1041720C Bicyclic amide derivatives, its prepn. method, medicinal compsns. and medical application |
| 01/19/1999 | US5861515 Esterification of protected baccatin iii or 10-deacetylbaccatin iii using a carboxylic acid substituted oxazolidine, then deprotecting and acylation |
| 01/19/1999 | US5861512 Reaction of 2-tert-butylcarboxamidepiperazine with acid in solvent, heating, dissolving, cooling, precipitation of crystals |
| 01/19/1999 | US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases |
| 01/19/1999 | US5861508 Purification of a cephalosporin salt |
| 01/19/1999 | US5861501 Capped synthetic RNA, analogs, and aptamers |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861493 Process for the synthesis of 2'-O-substituted pyrimidines |
| 01/19/1999 | US5861483 Inhibitor of stem cell proliferation and uses thereof |
| 01/19/1999 | US5861481 Peptide lung surfactants and therapeutic combinations |
| 01/19/1999 | US5861440 Cosmetic and medicinal topical preparations |
| 01/19/1999 | US5861438 Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists |
| 01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor |
| 01/19/1999 | US5861434 Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders |
| 01/19/1999 | US5861433 Prevention and improvement of inflammation caused by leucotriene B4 |
| 01/19/1999 | US5861432 Topical application |
| 01/19/1999 | US5861431 Incontinence treatment |
| 01/19/1999 | US5861430 Propolis extract; grampositive and gramnegative bacteria |
| 01/19/1999 | US5861429 13-substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests |
| 01/19/1999 | US5861428 Alleviation of osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis bullosa, inflammation, osteopenias, tempero |
| 01/19/1999 | US5861427 Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 01/19/1999 | US5861426 Nitro esters of aromatic compounds with amide or ester groups |
| 01/19/1999 | US5861425 Indole-ethanamines |
| 01/19/1999 | US5861424 Composition and method for treating cancer |
| 01/19/1999 | US5861422 Agonist-antagonist combination to reduce the use of nicotine and other drugs |
| 01/19/1999 | US5861419 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/19/1999 | US5861418 Aminobenzoic acid derivatives |
| 01/19/1999 | US5861415 Bioprotectant composition, method of use and extraction process of curcuminoids |
| 01/19/1999 | US5861414 Inhibiting blood platelet aggregation for antithrombotic disorders |
| 01/19/1999 | US5861413 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones |
| 01/19/1999 | US5861412 Dihydro-isoquinoline compounds and their use as pharmaceuticals |
| 01/19/1999 | US5861407 Tetrahydropyridine derivatives as dopamine receptor subtype ligands |
| 01/19/1999 | US5861406 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 01/19/1999 | US5861404 2,9-disubstituted purin-6-ones |
| 01/19/1999 | US5861402 1,4-dihydropyridine compounds |
| 01/19/1999 | US5861401 Treatment of congestive heart failure |
| 01/19/1999 | US5861399 Methods and compositions for the rapid and enduring relief of inadequate myocardial function |
| 01/19/1999 | US5861396 Purin-6-one derivatives |
| 01/19/1999 | US5861394 Use of N-substituted phenothiazines |
| 01/19/1999 | US5861393 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 01/19/1999 | US5861392 Therapeutic heterocycles |
| 01/19/1999 | US5861391 Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease |
| 01/19/1999 | US5861390 Treatment of breast cancer |
| 01/19/1999 | US5861389 Treating male menopause |
| 01/19/1999 | US5861387 Treatment and prevention of breast and endometrial cancer, bone loss, and for treating endometriosis |
| 01/19/1999 | US5861386 Prevention of loss of bone mass or bone minerals |
| 01/19/1999 | US5861385 Drug intermediates for compounds that lower cholesterol or treat hyperlipoproteinemia formed by reduction of acid or ester compounds with hydroxy or ether groups |
| 01/19/1999 | US5861384 Suppression of rejection after transplants for organs orally in an amount in the range of about 5 to 2000 mg. |
| 01/19/1999 | US5861382 Disaccharides and carboxylated and/or sulfated oligosaccharides are used for regulation of cytokine activity |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861312 Recognition component; hybridization; dna expression vectors; genetic engineering |
| 01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
| 01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 01/19/1999 | US5861281 Lacc |
| 01/19/1999 | US5861259 Immunoassays for human cyclin E |
| 01/19/1999 | US5861179 Treatment of epilepsy |
| 01/19/1999 | US5861173 Sustained release tablets with press coating on core of gel |
| 01/19/1999 | US5861172 Pharmaceutical formulations of compacted granulates of β-lactam antibiotics |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861170 Acetylsalicyclic acid-containing transdermal application system for antithrombotic therapy |
| 01/19/1999 | US5861168 Vessels suffering vascular injury from angioplasty are treated with arginine or lysine to reduce probabilty of restenosis |
| 01/19/1999 | US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| 01/19/1999 | US5861141 Pharmaceutical formulations of cefaclor |
| 01/19/1999 | US5861048 Dissolving aa alkaline earth metal or iron with a phosphorylated saccharide or one bound to a protein or peptide for use in feeds, fertilizers, foods beverages or tablets |
| 01/19/1999 | US5860977 Spine distraction implant and method |
| 01/19/1999 | US5860950 Arthroscopic irrigation solution and method for inhibition of pain and inflammation |
| 01/19/1999 | CA2179987C Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
| 01/19/1999 | CA2168865C Antiviral thiazoles |
| 01/19/1999 | CA2166902C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 01/19/1999 | CA2140874C Oral compositions |
| 01/19/1999 | CA2139552C Use of self-incompatibility receptor proteins (slg and srk) of plants for the treatment of allergic diseases |
| 01/19/1999 | CA2122923C Compositions for regulating skin wrinkles and/or skin atrophy |
| 01/19/1999 | CA2121484C Treatment of acne or of pseudofolliculitis barbae |
| 01/19/1999 | CA2089005C Method for inactivating pathogens in a body fluid |
| 01/19/1999 | CA2087540C Composition, method and kit for potentiating antitumor activity and for curing tumor |